Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to comprehensively monitor the effects of a nonsteroidal
antiandrogen in patients requiring hormone manipulation for prostate cancer